Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atavistik, Chiesi, Disc, Gen1e, Matisse, Personalis, Redhill, Vertanical, Xenix, Zai Lab.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Aditxt, Alembic, Artera, Cartesian, Exeltis, Ignite Proteomics, Novanta, Photocure, Riverpoint, Smart Eye, Standard Biotools, Treeline, Westgene.
Clinical updates for biopharma and med tech, including data readouts and publications: Alpha, Astrazeneca, Bial, DBV, Gilead, JCR, Merck, Neurocrine, Spruce, Teleflex, TG, Zetagen.
Biopharma and med-tech companies raising money in public or private financings, including: Aim Immunotech, Antogen, Cerus, City, Corvus, Dicot, Eloxx, Ideaya, Idorsia, Shattuck, Starton.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Artiva, Intrabio, Oncolys, Pfizer, Sanofi, Vcare, Vor, Remegen, Xspray.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Aclarion, Ayumi, Colospan, Corxel, Everest, Galmed, GNI, Karo, Lenz, Moberg, Novo Nordisk, Raymond, Sangamo, Senseonics, Takeda, Teva.